{"id":341,"date":"2023-02-01T10:05:28","date_gmt":"2023-02-01T09:05:28","guid":{"rendered":"https:\/\/semmelweis.hu\/amresu\/?page_id=341"},"modified":"2023-03-13T11:52:22","modified_gmt":"2023-03-13T10:52:22","slug":"knowledge-transfer","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/amresu\/knowledge-transfer\/","title":{"rendered":"Knowledge transfer"},"content":{"rendered":"

Publications<\/h3>\n

Selection of AmpC \u03b2-Lactamase Variants and Metallo-\u03b2-Lactamases Leading to Ceftolozane\/Tazobactam and Ceftazidime\/Avibactam Resistance during Treatment of MDR\/XDR Pseudomonas aeruginosa Infections.<\/span><\/a>\u00a0
\n<\/span>Ruedas-L\u00f3pez A, Alonso-Garc\u00eda I, Lasarte-Monterrubio C, Guijarro-S\u00e1nchez P, Gato E, V\u00e1zquez-Ucha JC, Vallejo JA, Fraile-Ribot PA, Fern\u00e1ndez-P\u00e9rez B, Velasco D, Guti\u00e9rrez-Urb\u00f3n JM, Ovia\u00f1o M, Beceiro A, Gonz\u00e1lez-Bello C, Oliver A, Arca-Su\u00e1rez J, Bou G.<\/span>Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0206721. doi: 10.1128\/AAC.02067-21. Epub 2021 Dec 20.PMID:\u202f34930034\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired \u03b2-lactamases: 2020 update.<\/span><\/a>\u00a0
\n<\/span>Del Barrio-Tofi\u00f1o E, L\u00f3pez-Causap\u00e9 C, Oliver A.<\/span>Int J Antimicrob Agents. 2020 Dec;56(6):106196. doi: 10.1016\/j.ijantimicag.2020.106196. Epub 2020 Oct 9.PMID:\u202f33045347\u202fReview.<\/span>\u00a0<\/span><\/p>\n

Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial.<\/span><\/a>\u00a0
\n<\/span>Torrens G, van der Schalk TE, Cortes-Lara S, Timbermont L, Del Barrio-Tofi\u00f1o E, Xavier BB, Zamorano L, Lammens C, Ali O, Ruzin A, Goossens H, Kumar-Singh S, Kluytmans J, Paling F, MacLean RC, K\u00f6hler T, L\u00f3pez-Causap\u00e9 C, Malhotra-Kumar S, Oliver A; ASPIRE-ICU study team.<\/span>J Antimicrob Chemother. 2022 Jun 29;77(7):1862-1872. doi: 10.1093\/jac\/dkac122.PMID:\u202f35451008\u202fClinical Trial.<\/span>\u00a0<\/span><\/p>\n

\u00a0<\/span>Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.<\/span><\/a>\u00a0
\n<\/span>Del Barrio-Tofi\u00f1o E, L\u00f3pez-Causap\u00e9 C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorl\u00ed L, Tubau F, G\u00f3mez-Zorrilla S, Tormo N, Dur\u00e1-Navarro R, Viedma E, Resino-Foz E, Fern\u00e1ndez-Mart\u00ednez M, Gonz\u00e1lez-Rico C, Alejo-Cancho I, Mart\u00ednez JA, Labayru-Echverria C, Due\u00f1as C, Ayestar\u00e1n I, Zamorano L, Martinez-Martinez L, Horcajada JP, Oliver A.<\/span>Antimicrob Agents Chemother. 2017 Oct 24;61(11):e01589-17. doi: 10.1128\/AAC.01589-17. Print 2017 Nov.PMID:\u202f28874376\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

Distinct epidemiology and resistance mechanisms affecting ceftolozane\/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS.<\/span><\/a>\u00a0
\n<\/span>Hern\u00e1ndez-Garc\u00eda M, Garc\u00eda-Castillo M, Garc\u00eda-Fern\u00e1ndez S, Melo-Cristino J, Pinto MF, Gon\u00e7alves E, Alves V, Vieira AR, Ramalheira E, Sancho L, Diogo J, Ferreira R, Silva T, Chaves C, Bou G, Cercenado E, Delgado-Valverde M, Oliver A, Pitart C, Rodr\u00edguez-Lozano J, Tormo N, Romano J, P\u00e1ssaro L, Paix\u00e3o L, L\u00f3pez-Mendoza D, D\u00edaz-Rega\u00f1\u00f3n J, Cant\u00f3n R; STEP and SUPERIOR study groups.<\/span>J Antimicrob Chemother. 2021 Jan 19;76(2):370-379. doi: 10.1093\/jac\/dkaa430.PMID:\u202f33099623<\/span>\u00a0<\/span><\/p>\n

Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane\/tazobactam and ceftazidime\/avibactam during treatment of XDR Pseudomonas aeruginosa infections.<\/span><\/a>\u00a0
\n<\/span>Arca-Su\u00e1rez J, Lasarte-Monterrubio C, Rodi\u00f1o-Janeiro BK, Cabot G, V\u00e1zquez-Ucha JC, Rodr\u00edguez-Iglesias M, Gal\u00e1n-S\u00e1nchez F, Beceiro A, Gonz\u00e1lez-Bello C, Oliver A, Bou G.<\/span>J Antimicrob Chemother. 2021 Jan 1;76(1):91-100. doi: 10.1093\/jac\/dkaa396.PMID:\u202f33083833<\/span>\u00a0<\/span><\/p>\n

Evaluation of in vitro activity of ceftazidime\/avibactam and ceftolozane\/tazobactam against MDR Pseudomonas aeruginosa isolates from Qatar.<\/span><\/a>
\n<\/span>Sid Ahmed MA, Abdel Hadi H, Hassan AAI, Abu Jarir S, Al-Maslamani MA, Eltai NO, Dousa KM, Hujer AM, Sultan AA, Soderquist B, Bonomo RA, Ibrahim EB, Jass J, Omrani AS.<\/span>J Antimicrob Chemother. 2019 Dec 1;74(12):3497-3504. doi: 10.1093\/jac\/dkz379.PMID:\u202f31504587\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

The ERACE-PA Global Surveillance Program: Ceftolozane\/tazobactam and Ceftazidime\/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa.<\/span><\/a>
\n<\/span>Gill CM, Akta\u00fe E, Alfouzan W, Bourassa L, Brink A, Burnham CD, Canton R, Carmeli Y, Falcone M, Kiffer C, Marchese A, Martinez O, Pournaras S, Satlin M, Seifert H, Thabit AK, Thomson KS, Villegas MV, Nicolau DP; ERACE-PA Global Study Group.<\/span>Eur J Clin Microbiol Infect Dis. 2021 Dec;40(12):2533-2541. doi: 10.1007\/s10096-021-04308-0. Epub 2021 Jul 22.PMID:\u202f34291323\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

Mechanisms leading to in vivo ceftolozane\/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa.<\/span><\/a>\u00a0
\n<\/span>Fraile-Ribot PA, Cabot G, Mulet X, Peria\u00f1ez L, Mart\u00edn-Pena ML, Juan C, P\u00e9rez JL, Oliver A.<\/span>J Antimicrob Chemother. 2018 Mar 1;73(3):658-663. doi: 10.1093\/jac\/dkx424.PMID:\u202f29149337<\/span>\u00a0<\/span><\/p>\n

Ceftazidime-avibactam and ceftolozane-tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary.<\/span><\/a>\u00a0
\n<\/span>O’Neall D, Juh\u00e1sz E, T\u00f3th \u00c1, Urb\u00e1n E, Szab\u00f3 J, Melegh S, Katona K, Krist\u00f3f K.<\/span>Acta Microbiol Immunol Hung. 2020 Mar 26;67(1):61-65. doi: 10.1556\/030.2020.01152.PMID:\u202f32208923<\/span>\u00a0<\/span><\/p>\n

Comparative analysis of in vitro dynamics and mechanisms of ceftolozane\/tazobactam and imipenem\/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones.<\/span><\/a>\u00a0
\n<\/span>Gomis-Font MA, Cabot G, L\u00f3pez-Arg\u00fcello S, Zamorano L, Juan C, Moy\u00e1 B, Oliver A.<\/span>J Antimicrob Chemother. 2022 Mar 31;77(4):957-968. doi: 10.1093\/jac\/dkab496.PMID:\u202f35084040<\/span>\u00a0<\/span><\/p>\n

\u202f<\/span>\u00a0<\/span>Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology.<\/span><\/a>\u00a0
\n<\/span>Del Barrio-Tofi\u00f1o E, Zamorano L, Cortes-Lara S, L\u00f3pez-Causap\u00e9 C, S\u00e1nchez-Diener I, Cabot G, Bou G, Mart\u00ednez-Mart\u00ednez L, Oliver A; GEMARA-SEIMC\/REIPI Pseudomonas study Group.<\/span>J Antimicrob Chemother. 2019 Jul 1;74(7):1825-1835. doi: 10.1093\/jac\/dkz147.PMID:\u202f30989186<\/span>\u00a0<\/span><\/p>\n

Implementation of the Infection Risk Scan (IRIS) in nine hospitals in the Belgian-Dutch border region (i-4-1-Health project).<\/span><\/a>\u00a0
\n<\/span>Verelst M, Willemsen I, Weterings V, De Waegemaeker P, Leroux-Roels I, Nieuwkoop E, Saegeman V, van Alphen L, van Kleef-van Koeveringe S, Kluytmans-van den Bergh M, Kluytmans J, Schuermans A; i-4-1-Health study group.<\/span>Antimicrob Resist Infect Control. 2022 Feb 28;11(1):43. doi: 10.1186\/s13756-022-01083-1.PMID:\u202f35227333\u202f<\/span>\u00a0<\/span><\/p>\n

Diversity in the Characteristics of\u202f<\/span>Klebsiella pneumoniae<\/span><\/i>\u202fST101 of Human, Environmental, and Animal Origin.<\/span><\/a>\u00a0
\n<\/span>De Koster S, Rodriguez Ruiz JP, Rajakani SG,\u202f<\/span>Lammens C<\/span><\/b>, Glupczynski Y, Goossens H, Xavier BB.<\/span>Front Microbiol. 2022 Feb 10;13:838207. doi: 10.3389\/fmicb.2022.838207. eCollection 2022.PMID:\u202f35222344\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

Obesity influences the microbiotic biotransformation of chlorogenic acid.<\/span><\/a>\u00a0
\n<\/span>Mortel\u00e9 O, Xavier BB,\u202f<\/span>Lammens C<\/span><\/b>, Malhotra-Kumar S, Jorens PG, Dirinck E, van Nuijs ALN, Hermans N.<\/span>J Pharm Biomed Anal. 2022 Mar 20;211:114550. doi: 10.1016\/j.jpba.2021.114550. Epub 2021 Dec 28.PMID:\u202f35124448<\/span>\u00a0<\/span><\/p>\n

The impact of non-antimicrobial drug agents on the acquisition of ESBL-producing Enterobacterales in non-critical care wards in a German university hospital: an exploratory, matched case-control study.<\/span><\/a>\u00a0
\n<\/span>Klauke P, Schwab F, Gastmeier P, Maechler F; R-GNOSIS WP5 study group.<\/span>J Antimicrob Chemother. 2021 Dec 24;77(1):229-236. doi: 10.1093\/jac\/dkab373.PMID:\u202f34791310<\/span>\u00a0<\/span><\/p>\n

Monitoring the SARS-CoV-2 pandemic: screening algorithm with single nucleotide polymorphism detection for the rapid identification of established and emerging variants.<\/span><\/a>\u00a0
\n<\/span>Mertens J, Coppens J, Loens K, Le Mercier M, Xavier BB,\u202f<\/span>Lammens C<\/span><\/b>, Vandamme S, Jansens H, Goossens H, Matheeussen V.<\/span>Clin Microbiol Infect. 2022 Jan;28(1):124-129. doi: 10.1016\/j.cmi.2021.09.007. Epub 2021 Sep 16.PMID:\u202f34537361\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

Novel vancomycin resistance gene cluster in\u202f<\/span>Enterococcus faecium<\/span><\/i>\u202fST1486, Belgium, June 2021.<\/span><\/a>\u00a0
\n<\/span>Xavier BB, Coppens J, De Koster S, Rajakani SG, Van Goethem S, Mzougui S, Anantharajah A,\u202f<\/span>Lammens C<\/span><\/b>, Loens K, Glupczynski Y, Goossens H, Matheeussen V.<\/span>Euro Surveill. 2021 Sep;26(36):2100767. doi: 10.2807\/1560-7917.ES.2021.26.36.2100767.PMID:\u202f34505571\u202f<\/span>Free\u00a0<\/span><\/b>\u00a0<\/span><\/p>\n

Assessing the Impact of Flavophospholipol and Virginiamycin Supplementation on the Broiler Microbiota: a Prospective Controlled Intervention Study.<\/span><\/a>\u00a0
\n<\/span>Mysara M, Berkell M, Xavier BB, De Backer S,\u202f<\/span>Lammens C<\/span><\/b>, Hautekiet V, Petkov S, Goossens H, Kumar-Singh S, Malhotra-Kumar S.<\/span>mSystems. 2021 Aug 31:e0038121. doi: 10.1128\/mSystems.00381-21. Online ahead of print.PMID:\u202f34463581\u202f<\/span>Free article.<\/span><\/b>\u00a0<\/span><\/p>\n

Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, Belgium.<\/span><\/a>\u00a0
\n<\/span>Mari\u00ebn J, Ceulemans A, Bakokimi D,\u202f<\/span>Lammens C<\/span><\/b>, Ieven M, Heytens S, De Sutter A, Verbakel JY, Van den Bruel A, Goossens H, Van Damme P, Ari\u00ebn KK, Coenen S.<\/span>Fam Pract. 2022 Jan 19;39(1):92-98. doi: 10.1093\/fampra\/cmab094.PMID:\u202f34448859<\/span>\u00a0<\/span><\/p>\n

ESBL-Producing, Carbapenem- and Ciprofloxacin-Resistant\u202f<\/span>Escherichia coli<\/span><\/i>\u202fin Belgian and Dutch Broiler and Pig Farms: A Cross-Sectional and Cross-Border Study.<\/span><\/a>\u00a0
\n<\/span>De Koster S, Ringenier M,\u202f<\/span>Lammens C<\/span><\/b>, Stegeman A, Tobias T, Velkers F, Vernooij H, Kluytmans-van den Bergh M, Kluytmans J, Dewulf J, Goossens H, On Behalf Of The I-Health Study Group.<\/span>Antibiotics (Basel). 2021 Aug 4;10(8):945. doi: 10.3390\/antibiotics10080945.PMID:\u202f34438995\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

Evaluation of GeneXpert PA assay compared to genomic and (semi-)quantitative culture methods for direct detection of Pseudomonas aeruginosa in endotracheal aspirates.<\/span><\/a>\u00a0
\n<\/span>van der Schalk TE, Coppens J, Timbermont L, Turlej-Rogacka A, Van Heirstraeten L, Berkell M, Yu L,\u202f<\/span>Lammens C<\/span><\/b>, Xavier BB, Matheeussen V, Ieven M, McCarthy M, Jorens PG, Ruzin A, Esser MT, Kumar-Singh S, Goossens H, Malhotra-Kumar S.<\/span>Antimicrob Resist Infect Control. 2021 Jul 23;10(1):110. doi: 10.1186\/s13756-021-00978-9.PMID:\u202f34301343\u202f<\/span>Free\u00a0<\/span><\/b>\u00a0<\/span><\/p>\n

Harmonization of whole-genome sequencing for outbreak surveillance of\u202f<\/span>Enterobacteriaceae<\/span><\/i>\u202fand\u202f<\/span>Enterococci<\/span><\/i>.<\/span><\/a>\u00a0
\n<\/span>Jamin C, De Koster S, van Koeveringe S, De Coninck D, Mensaert K, De Bruyne K, Perales Selva N,\u202f<\/span>Lammens C<\/span><\/b>, Goossens H, Hoebe C, Savelkoul P, van Alphen L.<\/span>Microb Genom. 2021 Jul;7(7):000567. doi: 10.1099\/mgen.0.000567.PMID:\u202f34279213\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

Phenotypic and genotypic characterization of mcr-1-positive multidrug-resistant Escherichia coli ST93, ST117, ST156, ST10, and ST744 isolated from poultry in Poland.<\/span><\/a>\u00a0
\n<\/span>\u0106wiek K, Wo\u017aniak-Biel A, Karwa\u0144ska M, Siedlecka M,\u202f<\/span>Lammens C<\/span><\/b>, Rebelo AR, Hendriksen RS, Kuczkowski M, Chmielewska-W\u0142adyka M, Wieliczko A.<\/span>Braz J Microbiol. 2021 Sep;52(3):1597-1609. doi: 10.1007\/s42770-021-00538-8. Epub 2021 Jun 10.PMID:\u202f34114111\u202f<\/span>\u00a0<\/span><\/p>\n

COMBACTE LAB-Net: building a European laboratory network for clinical trials on anti-infectives.<\/span><\/a>\u00a0
\n<\/span>Kostyanev T, Timbermont L, Vilken T,\u202f<\/span>Lammens C<\/span><\/b>, Malhotra-Kumar S, Glupczynski Y, Goossens H.<\/span>Future Microbiol. 2021 Jun;16:635-647. doi: 10.2217\/fmb-2021-0096. Epub 2021 May 17.PMID:\u202f33998261\u202f<\/span>\u00a0<\/span><\/p>\n

Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection.<\/span><\/a>\u00a0
\n<\/span>Wheatley R, Diaz Caballero J, Kapel N, de Winter FHR, Jangir P, Quinn A, Del Barrio-Tofi\u00f1o E, L\u00f3pez-Causap\u00e9 C, Hedge J, Torrens G, Van der Schalk T, Xavier BB, Fern\u00e1ndez-Cuenca F, Arenzana A, Recanatini C, Timbermont L, Sifakis F, Ruzin A, Ali O,\u202f<\/span>Lammens C<\/span><\/b>, Goossens H, Kluytmans J, Kumar-Singh S, Oliver A, Malhotra-Kumar S, MacLean C.<\/span>Nat Commun. 2021 Apr 28;12(1):2460. doi: 10.1038\/s41467-021-22814-9.PMID:\u202f33911082\u202f<\/span>\u00a0<\/span><\/p>\n

Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial.<\/span><\/a>\u00a0
\n<\/span>Fran\u00e7ois B, Jafri HS, Chastre J, S\u00e1nchez-Garc\u00eda M, Eggimann P, Dequin PF, Huberlant V, Vi\u00f1a Soria L, Boulain T, Bretonni\u00e8re C, Pugin J, Trenado J, Hernandez Padilla AC, Ali O, Shoemaker K, Ren P, Coenjaerts FE, Ruzin A, Barraud O, Timbermont L,\u202f<\/span>Lammens C<\/span><\/b>, Pierre V, Wu Y, Vignaud J, Colbert S, Bellamy T, Esser MT, Dubovsky F, Bonten MJ, Goossens H, Laterre PF; COMBACTE Consortium and the SAATELLITE Study Group.<\/span>Lancet Infect Dis. 2021 Sep;21(9):1313-1323. doi: 10.1016\/S1473-3099(20)30995-6. Epub 2021 Apr 21.PMID:\u202f33894131\u202fClinical Trial.<\/span>\u00a0<\/span><\/p>\n

Phenotypic and molecular characterizations of carbapenem-resistant Acinetobacter baumannii isolates collected within the EURECA study.<\/span><\/a>\u00a0
\n<\/span>Kostyanev T, Xavier BB, Garc\u00eda-Castillo M,\u202f<\/span>Lammens C<\/span><\/b>, Bravo-Ferrer Acosta J, Rodr\u00edguez-Ba\u00f1o J, Cant\u00f3n R, Glupczynski Y, Goossens H; EURECA\/WP1B Group.<\/span>Int J Antimicrob Agents. 2021 Jun;57(6):106345. doi: 10.1016\/j.ijantimicag.2021.106345. Epub 2021 Apr 20.PMID:\u202f33887390\u202f<\/span>\u00a0<\/span><\/p>\n

Microbiota-based markers predictive of development of Clostridioides difficile infection.<\/span><\/a>\u00a0
\n<\/span>Berkell M, Mysara M, Xavier BB, van Werkhoven CH, Monsieurs P,\u202f<\/span>Lammens C<\/span><\/b>, Ducher A, Vehreschild MJGT, Goossens H, de Gunzburg J, Bonten MJM, Malhotra-Kumar S; ANTICIPATE study group.<\/span>Nat Commun. 2021 Apr 14;12(1):2241. doi: 10.1038\/s41467-021-22302-0.PMID:\u202f33854066\u202f<\/span>\u00a0<\/span><\/p>\n

Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics.<\/span><\/a>\u00a0
\n<\/span>van Werkhoven CH, Ducher A, Berkell M, Mysara M,\u202f<\/span>Lammens C<\/span><\/b>, Torre-Cisneros J, Rodr\u00edguez-Ba\u00f1o J, Herghea D, Cornely OA, Biehl LM, Bernard L, Dominguez-Luzon MA, Maraki S, Barraud O, Nica M, Jazmati N, Sablier-Gallis F, de Gunzburg J, Mentr\u00e9 F, Malhotra-Kumar S, Bonten MJM, Vehreschild MJGT; ANTICIPATE Study Group.<\/span>Nat Commun. 2021 Apr 14;12(1):2240. doi: 10.1038\/s41467-021-22269-y.PMID:\u202f33854064\u202f<\/span>Free\u00a0<\/span><\/b>\u00a0<\/span><\/p>\n

Molecular pathways to high-level azithromycin resistance in Neisseria gonorrhoeae.<\/span><\/a>\u00a0
\n<\/span>Laumen JGE, Manoharan-Basil SS, Verhoeven E, Abdellati S, De Baetselier I, Crucitti T, Xavier BB, Chapelle S,\u202f<\/span>Lammens C<\/span><\/b>, Van Dijck C, Malhotra-Kumar S, Kenyon C.<\/span>J Antimicrob Chemother. 2021 Jun 18;76(7):1752-1758. doi: 10.1093\/jac\/dkab084.PMID:\u202f33760080<\/span>\u00a0<\/span><\/p>\n

Prospective One Health genetic surveillance in Vietnam identifies distinct bla<\/span>CTX-M<\/span>-harbouring Escherichia coli in food-chain and human-derived samples.<\/span><\/a>\u00a0
\n<\/span>Nguyen MN, Hoang HTT, Xavier BB,\u202f<\/span>Lammens C<\/span><\/b>, Le HT, Hoang NTB, Nguyen ST, Pham NT, Goossens H, Dang AD, Malhotra-Kumar S.<\/span>Clin Microbiol Infect. 2021 Oct;27(10):1515.e1-1515.e8. doi: 10.1016\/j.cmi.2021.01.006. Epub 2021 Jan 18.PMID:\u202f33476808\u202f<\/span>\u00a0<\/span><\/p>\n

Identification of\u202f<\/span>mcr-8<\/span><\/i>\u202fin Clinical Isolates From Qatar and Evaluation of Their Antimicrobial Profiles.<\/span><\/a>\u00a0
\n<\/span>Eltai NO, Kelly B, Al-Mana HA, Ibrahim EB, Yassine HM, Al Thani A, Al Maslmani M,\u202f<\/span>Lammens C<\/span><\/b>, Xavier BB, Malhotra-Kumar S.<\/span>Front Microbiol. 2020 Aug 24;11:1954. doi: 10.3389\/fmicb.2020.01954. eCollection 2020.PMID:\u202f32983006\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

Clonal transmission of multidrug-resistant Acinetobacter baumannii harbouring bla<\/span>OXA-24-like<\/span>\u202fand bla<\/span>OXA-23-like<\/span>\u202fgenes in a tertiary hospital in Albania.<\/span><\/a>\u00a0
\n<\/span>Tafaj S, Kostyanev T, Xavier BB, Fluit AC, Rodrigues CF,\u202f<\/span>Lammens C<\/span><\/b>, Osmalli D, Raka L, Goossens H, Malhotra-Kumar S, Bonten MJM.<\/span>J Glob Antimicrob Resist. 2020 Dec;23:79-81. doi: 10.1016\/j.jgar.2020.07.026. Epub 2020 Sep 2.PMID:\u202f32890841\u202f<\/span>Free article.<\/span><\/b>\u202fNo abstract available.<\/span>\u00a0<\/span><\/p>\n

International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April\/May 2020.<\/span><\/a>\u00a0
\n<\/span>Matheeussen V, Corman VM, Donoso Mantke O, McCulloch E,\u202f<\/span>Lammens C<\/span><\/b>, Goossens H, Niemeyer D, Wallace PS, Klapper P, Niesters HG, Drosten C, Ieven M; RECOVER project and collaborating networks.<\/span>Euro Surveill. 2020 Jul;25(27):2001223. doi: 10.2807\/1560-7917.ES.2020.25.27.2001223.PMID:\u202f32672149\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

Emergence of ST654 Pseudomonas aeruginosa co-harbouring bla<\/span>NDM-1<\/span>\u202fand bla<\/span>GES-5<\/span>\u202fin novel class I integron In1884 from Bulgaria.<\/span><\/a>\u00a0
\n<\/span>Kostyanev T, Nguyen MN, Markovska R, Stankova P, Xavier BB,\u202f<\/span>Lammens C<\/span><\/b>, Marteva-Proevska Y, Velinov T, Cant\u00f3n R, Goossens H, Malhotra-Kumar S.<\/span>J Glob Antimicrob Resist. 2020 Sep;22:672-673. doi: 10.1016\/j.jgar.2020.06.008. Epub 2020 Jun 22.PMID:\u202f32585404\u202f<\/span>Free article.<\/span><\/b>\u202fNo abstract available.<\/span>\u00a0<\/span><\/p>\n

ATP measurement as an objective method to measure environmental contamination in 9 hospitals in the Dutch\/Belgian border area.<\/span><\/a>\u00a0
\n<\/span>van Arkel A, Willemsen I, Kilsdonk-Bode L, Vlamings-Wagenaars S, van Oudheusden A, Waegemaeker P, Leroux-Roels I, Verelst M, Maas E, van Oosten A, Willemse P, van Asselen E, Klomp-Berens E, Franssen K, Van Cauwenberg E, Kluytmans J; i-4-1-Health Study Group.<\/span>Antimicrob Resist Infect Control. 2020 May 28;9(1):77. doi: 10.1186\/s13756-020-00730-9.PMID:\u202f32466792\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020.<\/span><\/a>\u00a0
\n<\/span>Matheeussen V, Loens K,\u202f<\/span>Lammens C<\/span><\/b>, Vilken T, Koopmans M, Goossens H, Ieven M; RECOVER consortium.<\/span>J Clin Virol. 2020 Jul;128:104432. doi: 10.1016\/j.jcv.2020.104432. Epub 2020 May 15.PMID:\u202f32422569\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

Quantifying antibiotic impact on within-patient dynamics of extended-spectrum beta-lactamase resistance.<\/span><\/a>
\nNiehus R, van Kleef E, Mo Y, Turlej-Rogacka A,\u202f<\/span>Lammens C<\/span><\/b>, Carmeli Y, Goossens H, Tacconelli E, Carevic B, Preotescu L, Malhotra-Kumar S, Cooper BS.<\/span>Elife. 2020 May 7;9:e49206. doi: 10.7554\/eLife.49206.PMID:\u202f32379042\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

Lower respiratory tract infection in the community: associations between viral aetiology and illness course.<\/span><\/a>\u00a0
\n<\/span>Vos LM, Bruyndonckx R, Zuithoff NPA, Little P, Oosterheert JJ, Broekhuizen BDL,\u202f<\/span>Lammens C<\/span><\/b>, Loens K, Viveen M, Butler CC, Crook D, Zlateva K, Goossens H, Claas ECJ, Ieven M, Van Loon AM, Verheij TJM, Coenjaerts FEJ; GRACE Consortium.<\/span>Clin Microbiol Infect. 2021 Jan;27(1):96-104. doi: 10.1016\/j.cmi.2020.03.023. Epub 2020 Mar 31.PMID:\u202f32244051\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

BacPipe: A Rapid, User-Friendly Whole-Genome Sequencing Pipeline for Clinical Diagnostic Bacteriology.<\/span><\/a>\u00a0
\n<\/span>Xavier BB, Mysara M, Bolzan M, Ribeiro-Gon\u00e7alves B, Alako BTF, Harrison P,\u202f<\/span>Lammens C<\/span><\/b>, Kumar-Singh S, Goossens H, Carri\u00e7o JA, Cochrane G, Malhotra-Kumar S.<\/span>iScience. 2020 Jan 24;23(1):100769. doi: 10.1016\/j.isci.2019.100769. Epub 2019 Dec 12.PMID:\u202f31887656\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

Mechanical Ventilation Impairs IL-17 Cytokine Family Expression in Ventilator-Associated Pneumonia.<\/span><\/a>\u00a0
\n<\/span>De Winter FHR, ‘s Jongers B, Bielen K, Mancuso D, Timbermont L,\u202f<\/span>Lammens C<\/span><\/b>, Van Averbeke V, Boddaert J, Ali O, Kluytmans J, Ruzin A, Malhotra-Kumar S, Jorens PG, Goossens H, Kumar-Singh S.<\/span>Int J Mol Sci. 2019 Oct 12;20(20):5072. doi: 10.3390\/ijms20205072.PMID:\u202f31614857\u202f<\/span>Free PMC article.<\/span><\/b>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Publications Selection of AmpC \u03b2-Lactamase Variants and Metallo-\u03b2-Lactamases Leading to Ceftolozane\/Tazobactam and Ceftazidime\/Avibactam Resistance during Treatment of MDR\/XDR Pseudomonas aeruginosa Infections.<\/a> \u00a0 Ruedas-L\u00f3pez A, Alonso-Garc\u00eda I, Lasarte-Monterrubio C, Guijarro-S\u00e1nchez P, Gato E, V\u00e1zquez-Ucha JC, Vallejo JA, Fraile-Ribot PA, Fern\u00e1ndez-P\u00e9rez B, Velasco D, Guti\u00e9rrez-Urb\u00f3n JM, Ovia\u00f1o M, Beceiro A, Gonz\u00e1lez-Bello C, Oliver A, Arca-Su\u00e1rez J, Bou G.Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0206721. doi: 10.1128\/AAC.02067-21. Epub 2021 Dec 20.PMID:\u202f34930034\u202fFree PMC article.\u00a0 Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired \u03b2-lactamases: 2020 update.<\/a> \u00a0 Del Barrio-Tofi\u00f1o E, L\u00f3pez-Causap\u00e9 C, …<\/p>\n","protected":false},"author":182,"featured_media":0,"parent":0,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-341","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/amresu\/wp-json\/wp\/v2\/pages\/341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/amresu\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/amresu\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/amresu\/wp-json\/wp\/v2\/users\/182"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/amresu\/wp-json\/wp\/v2\/comments?post=341"}],"version-history":[{"count":2,"href":"https:\/\/semmelweis.hu\/amresu\/wp-json\/wp\/v2\/pages\/341\/revisions"}],"predecessor-version":[{"id":351,"href":"https:\/\/semmelweis.hu\/amresu\/wp-json\/wp\/v2\/pages\/341\/revisions\/351"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/amresu\/wp-json\/wp\/v2\/media?parent=341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/amresu\/wp-json\/wp\/v2\/categories?post=341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/amresu\/wp-json\/wp\/v2\/tags?post=341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}